# Phase 4 infarction trials recruiting: 40 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 40 trials in phase 4 for infarction that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 infarction trials: 40 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/infarction

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 40
- Recruiting or not yet: 40
- Read on: November 19, 2026

## Trials

The 25 newest of 40, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939516 | Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome | Medisch Spectrum Twente | Phase 4 | Not yet recruiting | Acute Coronary Syndromes (ACS), Unstable Angina Pectoris, Myocardial Infarction (MI), STEMI, NSTEMI | 3,120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939516) |
| November 3, 2026 | NCT07912801 | Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery | Peking University First Hospital | Phase 4 | Not yet recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Hypoxia-Inducible Factor 1, Alpha Subunit, Prolyl-Hydroxylase... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912801) |
| October 15, 2026 | NCT07875179 | IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI | The Affiliated Hospital of Xuzhou Medical University | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction (STEMI) | 3,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875179) |
| September 18, 2026 | NCT07828210 | NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke | EVD Pharmacy and Medical Company Limited | Phase 4 | Recruiting | Stroke, Stroke, Acute Ischemic, Stroke, Ischemic, Stroke, Cryptogenic, Stroke, Cardiovascular | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828210) |
| September 17, 2026 | NCT07824323 | Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome | Taipei Medical University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, Dyslipidemia | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824323) |
| August 31, 2026 | NCT07795398 | DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease | Odense University Hospital | Phase 4 | Recruiting | Ischemic Heart Disease, Ischemic Heart Disease Chronic, Chronic Coronary Syndrome, Myocardial Infarction, Percutaneous... | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795398) |
| July 6, 2026 | NCT07684742 | Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Gyeongsang National University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684742) |
| June 11, 2026 | NCT07641231 | Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641231) |
| June 1, 2026 | NCT07617376 | Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions | Wroclaw Medical University | Phase 4 | Recruiting | Myocardial Infarction, Decompensated Chronic Heart Failure, Acute Heart Failure (AHF), Pulmonary Embolism Acute... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617376) |
| May 8, 2026 | NCT07575984 | Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke | Pharmasoft | Phase 4 | Recruiting | Ischemic Stroke | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575984) |
| May 4, 2026 | NCT07563673 | Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC） | Beijing Chao Yang Hospital | Phase 4 | Not yet recruiting | Cerebral Infarction, Thrombolysis | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563673) |
| April 24, 2026 | NCT07549282 | Intranasal Dexmedetomidine and Perioperative Myocardial Injury | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | Coronary Heart Disease, Myocardial Injury, Myocardial Infarction, Dexmedetomidine | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07549282) |
| April 17, 2026 | NCT07536802 | Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Recruiting | ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon, Coronary Slow Flow, Acute Myocardial... | 1,148 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536802) |
| April 6, 2026 | NCT07511257 | Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 4 | Recruiting | Coronary Artery Ectasia, Acute Coronary Syndromes (ACS), STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST... | 326 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511257) |
| April 2, 2026 | NCT07507500 | Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Phase 4 | Recruiting | Myocardial Infarction (MI) | 8,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507500) |
| March 17, 2026 | NCT07476859 | Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome | Fundación para la Investigación del Hospital Clínico de Valencia | Phase 4 | Recruiting | Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More) | 538 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476859) |
| December 18, 2025 | NCT07290699 | Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period | Second Affiliated Hospital of Nanchang University | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) | 2,442 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07290699) |
| October 2, 2025 | NCT07203846 | Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor | Collegium Medicum w Bydgoszczy | Phase 4 | Not yet recruiting | ACS - Acute Coronary Syndrome, Ticagrelor, Microbiota, Platelet Aggregation, Myocardial Infarction (MI), Blood... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07203846) |
| September 29, 2025 | NCT07195812 | Rivaroxaban for Slow Coronary Flow After PCI in STEMI | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction, No-Reflow Phenomenon | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195812) |
| June 5, 2025 | NCT07007143 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 1,032 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07007143) |
| March 30, 2025 | NCT06901466 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06901466) |
| January 22, 2025 | NCT06787430 | Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | STEMI - ST-segment Elevation Myocardial Infarction | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06787430) |
| January 10, 2025 | NCT06769256 | Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden | Henan Institute of Cardiovascular Epidemiology | Phase 4 | Recruiting | ST-segment Elevation Myocardial Infarction (STEMI) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06769256) |
| January 3, 2025 | NCT06757764 | The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis | Asan Medical Center | Phase 4 | Recruiting | Cerebral Infarction, Stenosis Artery | 2,340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06757764) |
| January 3, 2025 | NCT06756945 | Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial | Beijing Anzhen Hospital | Phase 4 | Not yet recruiting | ST-elevation Myocardial Infarction (STEMI) | 3,612 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06756945) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Wroclaw Medical University | 2 |
| EVD Pharmacy and Medical Company Limited | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| Beijing Anzhen Hospital | 1 |
| Penza State University | 1 |
| Collegium Medicum w Bydgoszczy | 1 |
| Asan Medical Center | 1 |
| Henan Institute of Cardiovascular Epidemiology | 1 |
| Medisch Spectrum Twente | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Research Maatschap Cardiologen Rotterdam Zuid | 1 |
| Beijing Chao Yang Hospital | 1 |
| National Institute of Cardiovascular Diseases, Pakistan | 1 |
| Spanish Society of Cardiology | 1 |
| St. Antonius Hospital | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |
| Instituto Nacional de Cardiologia Ignacio Chavez | 1 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 1 |
| Peking University First Hospital | 1 |
| Gyeongsang National University Hospital | 1 |
| Samsung Medical Center | 1 |
| The Affiliated Hospital of Xuzhou Medical University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 9 |
| South Korea | 5 |
| Poland | 4 |
| Netherlands | 4 |
| Russia | 3 |
| Spain | 2 |
| Belgium | 2 |
| Denmark | 2 |
| Vietnam | 1 |
| Ireland | 1 |
| Latvia | 1 |
| Norway | 1 |
| Czechia | 1 |
| Germany | 1 |
| Italy | 1 |
| Serbia | 1 |
| Pakistan | 1 |
| Mexico | 1 |
| France | 1 |
| Nepal | 1 |
| Sweden | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
- [Women's health clinics in the United States](https://specstream.ai/data/businesses/womens-health-clinics/united-states)
- [Medical schools in the United States](https://specstream.ai/data/businesses/medical-schools/united-states)
- [Child psychiatry practices in the United States](https://specstream.ai/data/businesses/child-psychiatry-practices/united-states)
- [Salvadoran restaurants in the United States](https://specstream.ai/data/businesses/salvadoran-restaurants/united-states)
- [Furniture wholesalers in the United States](https://specstream.ai/data/businesses/furniture-wholesalers/united-states)
